ISSUES FOR URGENT RESOLUTION BY ARPANSA
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is the national regulator of all federal government aspects of nuclear and radiation sources and activities with the prime objective of protecting and keeping safe the nation’s population and environment from the harmful effects of radiation and other nuclear pursuits.
In its regulatory role ARPANSA will shortly have to address issues linked to nuclear waste and collectively are probably the most important and significant situation that has had to be dealt with by ARPANSA since its foundation over twenty years ago
ANSTO VIABILITY
The first is the need for ARPANSA to obtain an independent andcomprehensive assessment and report on the proposed increased
production of nuclear medicine by reactor generation by the AustralianmNuclear Science and Technology Organisation (ANSTO) at its Lucas Heights precinct
The reason behind this is that ANSTO is relying on its production of nuclear medicine as the mainstay of its activities and intends to become a major international producer and exporter of reactor generated nuclear medicine.
However this appears to be a misconceived and purposeless intention since nuclear medicine generated by reactor isotopes is in significant decline throughout the world due to its dangerous inherent state in being used in medical diagnosis and treatment
There is a world wide turning away by the medical profession from using reactor generated nuclear medicine because of its sever danger to patients coupled with its extremely high production costs.
More alternatives to this form of nuclear medicine are already extensively used as they are far safer and pose little risk to patients and additionally are much cheaper to produce with the involvement of major international drug companies
ARPANSA should seek the independent and expert assessment and review of the proposal and intentions by ANSTO as part of the licensing process for the increased storage facility for nuclear waste at Lucas Heights recently proposed by ANSTO
The assessment and review must include a financial examination to determine commercial and economic viability of the activities and proposals by ANSTO as this is an essential ingredient of the qualifications for the licence for the increased storage capacity
Since the suitably qualified experts for the assessment are not in Australia (as in any case this could create a conflict situation) ARPANSA will need to rely on and engage the highly qualified experts in this field available
from overseas
From the general tenor and prescriptions of the Australian Radiation Protection and Nuclear Safety Act 1998 and applicable regulations – which are referred to as the enabling legislation – it seems quite certain that the commercial and financial aspects must be included by ARPANSAin considering an application for a licence
This should be even more imperative since the funds sought by ANSTO for the increased storage capability at Lucas Heights are being provided by the federal government which is in direct and colloquial terms taxpayers’ money and it is an obligation of the government to protect public revenue and expenditure
There has never been any publicly released information by ANSTO on the financial aspects of the production and sale of its nuclear medicine but as justification for the production ANSTO has relied on the emotivearguments that in their lifetime everyone has or will have a need for nuclear medicine.
ANSTO claims that it has given to the government a recently commissioned independent study into future nuclear medicine supply in Australia and this study should be given to ARPANSA with all supporting information for assistance for its assessment and review as part of the licensing process.